Episodic twice-daily treatment for recurrent genital herpes. 1988

L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
Department of Dermatology, Baylor College of Medicine, Houston, Texas 77030.

A new dosage regimen of orally administered acyclovir, 800 mg twice daily for five days, for the treatment of recurrent genital herpes was compared with the standard dosage of 200 mg given five times per day. A double-blind study of 157 patients was used to evaluate the safety and efficacy of both regimens. The new regimen was well tolerated, more convenient, and as effective as the standard dosage. In male patients, the new regimen may be more effective than the standard regimen of 200 mg given five times per day to treat lesions that are already present.

UI MeSH Term Description Entries
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006558 Herpes Genitalis Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females. Genital Herpes,Herpes Simplex, Genital,Herpes Simplex Virus Genital Infection,Genital Herpes Simplex,Herpes, Genital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
March 2003, Sexually transmitted diseases,
L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
January 1987, Scandinavian journal of infectious diseases,
L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
October 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
July 2007, International journal of STD & AIDS,
L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
October 1999, The Journal of antimicrobial chemotherapy,
L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
February 1988, Journal of consulting and clinical psychology,
L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
July 1999, Obstetrics and gynecology,
L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
January 1952, Revista medica del Hospital Espanol,
L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
February 2008, Current opinion in infectious diseases,
L H Goldberg, and R Kaufman, and M A Conant, and J Sperber, and M L Allen, and M Illeman, and P S Donohew, and S Chapman
July 1996, JAMA,
Copied contents to your clipboard!